SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '5e84'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1C8L_A_CFFA940_1 (PROTEIN (GLYCOGEN PHOSPHORYLASE))	5e84	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	4 / 6	ASN A 177 PHE A 176 ALA A 179 GLY A 100	None	1.08A	1c8lA-5e84A: undetectable	1c8lA-5e84A: 21.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1FBM_B_RTLB951_0 (PROTEIN (CARTILAGE OLIGOMERIC MATRIX PROTEIN))	5e84	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	4 / 4	THR A 557 LEU A 561 LEU A 568 GLN A 571	None	1.16A	1fbmA-5e84A: undetectable	1fbmA-5e84A: 5.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1GFZ_A_CFFA940_1 (GLYCOGEN PHOSPHORYLASE)	5e84	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	4 / 6	ASN A 177 PHE A 176 ALA A 179 GLY A 100	None	1.06A	1gfzA-5e84A: undetectable	1gfzA-5e84A: 21.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1L5Q_A_CFFA863_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	5e84	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	4 / 6	ASN A 177 PHE A 176 ALA A 179 GLY A 100	None	1.06A	1l5qA-5e84A: undetectable	1l5qA-5e84A: 22.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1L5Q_B_CFFB1863_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	5e84	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	4 / 6	ASN A 177 PHE A 176 ALA A 179 GLY A 100	None	1.04A	1l5qB-5e84A: undetectable	1l5qB-5e84A: 22.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1L7X_A_CFFA863_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	5e84	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	4 / 6	ASN A 177 PHE A 176 ALA A 179 GLY A 100	None	1.03A	1l7xA-5e84A: undetectable	1l7xA-5e84A: 22.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1L7X_B_CFFB1863_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	5e84	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	4 / 6	ASN A 177 PHE A 176 ALA A 179 GLY A 100	None	1.05A	1l7xB-5e84A: undetectable	1l7xB-5e84A: 22.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1QHS_A_CLMA999_0 (PROTEIN (CHLORAMPHENICOL PHOSPHOTRANSFERASE))	5e84	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	6 / 12	VAL A 342 ILE A 359 ILE A 356 PHE A 379 VAL A 345 LEU A 234	None	1.38A	1qhsA-5e84A: undetectable	1qhsA-5e84A: 16.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1RJD_A_SAMA801_0 (CARBOXY METHYL TRANSFERASE FOR PROTEIN PHOSPHATASE 2A CATALYTIC SUBUNIT)	5e84	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	5 / 12	ILE A 371 GLY A 254 GLY A 227 LEU A 334 LEU A 253	None None ATP A 801 (-3.8A) None None	1.09A	1rjdA-5e84A: undetectable	1rjdA-5e84A: 21.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1RJD_B_SAMB802_0 (CARBOXY METHYL TRANSFERASE FOR PROTEIN PHOSPHATASE 2A CATALYTIC SUBUNIT)	5e84	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	5 / 12	ILE A 371 GLY A 254 GLY A 227 LEU A 334 LEU A 253	None None ATP A 801 (-3.8A) None None	1.07A	1rjdB-5e84A: undetectable	1rjdB-5e84A: 21.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1RJD_C_SAMC803_0 (CARBOXY METHYL TRANSFERASE FOR PROTEIN PHOSPHATASE 2A CATALYTIC SUBUNIT)	5e84	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	5 / 12	ILE A 371 GLY A 254 GLY A 227 LEU A 334 LEU A 253	None None ATP A 801 (-3.8A) None None	1.06A	1rjdC-5e84A: undetectable	1rjdC-5e84A: 21.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2B82_B_ADNB1002_1 (CLASS B ACID PHOSPHATASE)	5e84	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	5 / 9	PHE A 612 LYS A 616 LEU A 601 TRP A 600 THR A 557	None	1.35A	2b82B-5e84A: undetectable	2b82B-5e84A: 16.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2BM9_C_SAMC301_1 (CEPHALOSPORIN HYDROXYLASE CMCI)	5e84	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	4 / 4	SER A 146 ASP A 94 ARG A 289 ASP A 259	None None None ATP A 801 ( 4.9A)	1.48A	2bm9C-5e84A: undetectable	2bm9C-5e84A: 15.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2IEO_A_017A402_1 (PROTEASE)	5e84	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	5 / 12	LEU A 35 ASP A 391 VAL A 394 GLY A 226 PRO A 173	None None None ATP A 801 (-3.3A) ZN A 806 ( 4.6A)	0.95A	2ieoA-5e84A: undetectable	2ieoA-5e84A: 11.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2IEO_A_017A402_2 (PROTEASE)	5e84	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	5 / 12	LEU A 35 ASP A 391 VAL A 394 GLY A 226 PRO A 173	None None None ATP A 801 (-3.3A) ZN A 806 ( 4.6A)	0.89A	2ieoB-5e84A: undetectable	2ieoB-5e84A: 11.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Q6O_B_SAMB500_0 (HYPOTHETICAL PROTEIN)	5e84	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	4 / 6	ASP A 224 VAL A 362 PRO A 173 THR A 171	ZN A 806 (-2.7A) None ZN A 806 ( 4.6A) None	1.43A	2q6oB-5e84A: undetectable	2q6oB-5e84A: 18.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2YA7_C_ZMRC1776_2 (NEURAMINIDASE A)	5e84	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	4 / 6	ASP A 186 ILE A 190 GLU A 533 TYR A 127	None	1.34A	2ya7C-5e84A: undetectable	2ya7C-5e84A: 22.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3AOB_C_RFPC2002_1 (ACRIFLAVINE RESISTANCE PROTEIN B)	5e84	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	5 / 12	ALA A 179 THR A 102 GLY A 476 ARG A 528 LEU A 424	None	1.43A	3aobC-5e84A: 2.9	3aobC-5e84A: 19.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ARR_A_PNXA606_1 (CHITINASE A)	5e84	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	4 / 7	GLY A 210 LYS A 213 ASP A 357 TYR A 209	None	1.34A	3arrA-5e84A: undetectable	3arrA-5e84A: 23.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3BCR_A_AZZA940_1 (GLYCOGEN PHOSPHORYLASE, MUSCLE FORM)	5e84	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	4 / 5	ASN A 177 PHE A 176 ALA A 179 GLY A 100	None	1.11A	3bcrA-5e84A: undetectable	3bcrA-5e84A: 21.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3CYW_A_017A201_1 (HIV-1 PROTEASE)	5e84	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	5 / 12	LEU A 35 ASP A 391 VAL A 394 GLY A 226 PRO A 173	None None None ATP A 801 (-3.3A) ZN A 806 ( 4.6A)	0.86A	3cywA-5e84A: undetectable	3cywA-5e84A: 11.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3D20_A_017A201_2 (HIV-1 PROTEASE)	5e84	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	5 / 12	LEU A 35 ASP A 391 VAL A 394 GLY A 226 PRO A 173	None None None ATP A 801 (-3.3A) ZN A 806 ( 4.6A)	0.90A	3d20B-5e84A: undetectable	3d20B-5e84A: 11.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3DD1_A_CFFA903_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	5e84	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	4 / 6	ASN A 177 PHE A 176 ALA A 179 GLY A 100	None	1.07A	3dd1A-5e84A: undetectable	3dd1A-5e84A: 22.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3DD1_B_CFFB903_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	5e84	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	4 / 6	ASN A 177 PHE A 176 ALA A 179 GLY A 100	None	1.06A	3dd1B-5e84A: undetectable	3dd1B-5e84A: 22.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3DDS_A_CFFA904_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	5e84	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	4 / 6	ASN A 177 PHE A 176 ALA A 179 GLY A 100	None	1.06A	3ddsA-5e84A: undetectable	3ddsA-5e84A: 22.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3DDS_B_CFFB903_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	5e84	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	4 / 6	ASN A 177 PHE A 176 ALA A 179 GLY A 100	None	1.04A	3ddsB-5e84A: undetectable	3ddsB-5e84A: 22.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3DDW_A_CFFA903_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	5e84	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	4 / 6	ASN A 177 PHE A 176 ALA A 179 GLY A 100	None	1.08A	3ddwA-5e84A: undetectable	3ddwA-5e84A: 22.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3DDW_B_CFFB903_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	5e84	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	4 / 6	ASN A 177 PHE A 176 ALA A 179 GLY A 100	None	1.06A	3ddwB-5e84A: undetectable	3ddwB-5e84A: 22.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3EKT_D_017D200_2 (PROTEASE)	5e84	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	5 / 11	LEU A 35 ASP A 391 VAL A 394 GLY A 226 PRO A 173	None None None ATP A 801 (-3.3A) ZN A 806 ( 4.6A)	0.89A	3ektD-5e84A: undetectable	3ektD-5e84A: 10.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3HLW_B_CE3B302_2 (CTX-M-9 EXTENDED-SPECTRUM BETA-LACTAMASE)	5e84	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	3 / 3	CYH A 41 PRO A 63 ASP A 391	None	0.94A	3hlwB-5e84A: undetectable	3hlwB-5e84A: 19.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3J6P_B_TA1B502_1 (TUBULIN BETA CHAIN)	5e84	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	5 / 12	VAL A 345 ASP A 348 SER A 233 PRO A 421 LEU A 422	None	1.31A	3j6pB-5e84A: undetectable	3j6pB-5e84A: 20.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3LZU_A_017A200_1 (HIV-1 PROTEASE)	5e84	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	5 / 12	LEU A 35 ASP A 391 VAL A 394 GLY A 226 PRO A 173	None None None ATP A 801 (-3.3A) ZN A 806 ( 4.6A)	0.90A	3lzuA-5e84A: undetectable	3lzuA-5e84A: 11.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3MBG_A_ACTA207_0 (FAD-LINKED SULFHYDRYL OXIDASE ALR)	5e84	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	4 / 7	GLU A 201 LYS A 96 ASP A 231 ALA A 229	ZN A 806 ( 2.6A) ATP A 801 (-2.3A) ZN A 806 (-2.8A) ATP A 801 (-4.1A)	1.17A	3mbgA-5e84A: undetectable 3mbgB-5e84A: undetectable	3mbgA-5e84A: 11.55 3mbgB-5e84A: 11.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3OXX_A_DR7A100_1 (HIV-1 PROTEASE)	5e84	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	5 / 12	LEU A 35 ASP A 391 VAL A 394 GLY A 226 PRO A 173	None None None ATP A 801 (-3.3A) ZN A 806 ( 4.6A)	0.88A	3oxxA-5e84A: undetectable	3oxxA-5e84A: 11.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3S3M_A_DLUA398_1 (PFV INTEGRASE)	5e84	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	4 / 8	ASP A 224 GLY A 364 TYR A 39 GLU A 201	ZN A 806 (-2.7A) ATP A 801 (-3.1A) ATP A 801 (-4.8A) ZN A 806 ( 2.6A)	0.88A	3s3mA-5e84A: 3.7	3s3mA-5e84A: 22.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3S3N_A_DLUA398_1 (PFV INTEGRASE)	5e84	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	4 / 8	ASP A 224 GLY A 364 TYR A 39 GLU A 201	ZN A 806 (-2.7A) ATP A 801 (-3.1A) ATP A 801 (-4.8A) ZN A 806 ( 2.6A)	0.90A	3s3nA-5e84A: 3.5	3s3nA-5e84A: 22.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3SPK_B_TPVB100_2 (HIV-1 PROTEASE)	5e84	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	5 / 12	LEU A 35 ASP A 391 VAL A 394 GLY A 226 PRO A 173	None None None ATP A 801 (-3.3A) ZN A 806 ( 4.6A)	0.98A	3spkB-5e84A: undetectable	3spkB-5e84A: 10.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4A97_B_ZPCB1318_1 (CYS-LOOP LIGAND-GATED ION CHANNEL)	5e84	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	5 / 12	PHE A 544 ILE A 145 GLU A 547 GLU A 155 VAL A 92	None	1.41A	4a97A-5e84A: 2.7 4a97B-5e84A: 4.0	4a97A-5e84A: 19.60 4a97B-5e84A: 19.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4K50_I_ACTI504_0 (RNA POLYMERASE 3D-POL)	5e84	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	3 / 3	VAL A 66 GLY A 77 LYS A 81	None	0.52A	4k50I-5e84A: undetectable	4k50I-5e84A: 23.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4MM4_A_8PRA603_1 (TRANSPORTER)	5e84	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	5 / 12	ALA A 398 TYR A 396 PHE A 45 GLY A 43 THR A 411	None	1.36A	4mm4A-5e84A: undetectable	4mm4A-5e84A: 22.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4NJU_A_TPVA500_1 (PROTEASE)	5e84	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	5 / 12	LEU A 35 ASP A 391 VAL A 394 GLY A 226 PRO A 173	None None None ATP A 801 (-3.3A) ZN A 806 ( 4.6A)	0.87A	4njuA-5e84A: undetectable	4njuA-5e84A: 10.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4NJU_C_TPVC500_1 (PROTEASE)	5e84	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	5 / 12	LEU A 35 ASP A 391 VAL A 394 GLY A 226 PRO A 173	None None None ATP A 801 (-3.3A) ZN A 806 ( 4.6A)	0.87A	4njuC-5e84A: undetectable	4njuC-5e84A: 10.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4O1E_A_C2FA3000_0 (DIHYDROPTEROATE SYNTHASE DHPS)	5e84	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	5 / 12	GLU A 143 ILE A 534 GLY A 100 LYS A 123 ILE A 99	None	1.07A	4o1eA-5e84A: undetectable	4o1eA-5e84A: 18.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4OBW_A_SAMA602_0 (2-METHOXY-6-POLYPREN YL-1,4-BENZOQUINOL METHYLASE, MITOCHONDRIAL)	5e84	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	5 / 12	GLY A 216 ILE A 220 ASN A 219 GLY A 210 PHE A 242	None	1.24A	4obwA-5e84A: undetectable	4obwA-5e84A: 18.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4OBW_B_SAMB601_0 (2-METHOXY-6-POLYPREN YL-1,4-BENZOQUINOL METHYLASE, MITOCHONDRIAL)	5e84	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	5 / 12	ALA A 229 GLY A 228 GLY A 227 ASP A 94 GLY A 249	ATP A 801 (-4.1A) ATP A 801 (-4.1A) ATP A 801 (-3.8A) None None	1.00A	4obwB-5e84A: undetectable	4obwB-5e84A: 18.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4OBW_C_SAMC601_0 (2-METHOXY-6-POLYPREN YL-1,4-BENZOQUINOL METHYLASE, MITOCHONDRIAL)	5e84	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	5 / 12	GLY A 216 ILE A 220 ASN A 219 GLY A 210 PHE A 242	None	1.22A	4obwC-5e84A: undetectable	4obwC-5e84A: 18.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4OBW_D_SAMD601_0 (2-METHOXY-6-POLYPREN YL-1,4-BENZOQUINOL METHYLASE, MITOCHONDRIAL)	5e84	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	5 / 12	GLY A 216 ILE A 220 ASN A 219 GLY A 210 PHE A 242	None	1.24A	4obwD-5e84A: undetectable	4obwD-5e84A: 18.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4PM5_A_CE3A301_2 (BETA-LACTAMASE CTX-M-14)	5e84	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	3 / 3	CYH A 41 PRO A 63 ASP A 391	None	0.93A	4pm5A-5e84A: undetectable	4pm5A-5e84A: 18.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QWP_B_GCSB307_1 (CHITOSANASE)	5e84	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	4 / 7	GLU A 201 THR A 37 GLY A 36 THR A 38	ZN A 806 ( 2.6A) ATP A 801 (-4.0A) ATP A 801 (-3.2A) ATP A 801 (-3.5A)	0.90A	4qwpB-5e84A: 2.2	4qwpB-5e84A: 18.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4ZGF_A_BEZA210_0 (UNCHARACTERIZED PROTEIN)	5e84	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	4 / 4	VAL A 66 ALA A 67 ASN A 90 GLN A 83	None	1.42A	4zgfA-5e84A: undetectable	4zgfA-5e84A: 12.87
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5AQF_A_ADNA1382_1 (HEAT SHOCK COGNATE 71 KDA PROTEIN)	5e84	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	6 / 10	GLY A 226 GLY A 254 GLU A 256 GLY A 364 SER A 365 ILE A 368	ATP A 801 (-3.3A) None None ATP A 801 (-3.1A) ATP A 801 (-3.8A) ATP A 801 (-4.7A)	1.47A	5aqfA-5e84A: 48.2	5aqfA-5e84A: 69.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5AQF_A_ADNA1382_1 (HEAT SHOCK COGNATE 71 KDA PROTEIN)	5e84	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	9 / 10	GLY A 226 GLY A 255 LYS A 296 ARG A 297 SER A 300 GLY A 364 SER A 365 ARG A 367 ILE A 368	ATP A 801 (-3.3A) ATP A 801 (-3.5A) ATP A 801 (-2.7A) ATP A 801 (-3.8A) ATP A 801 (-2.6A) ATP A 801 (-3.1A) ATP A 801 (-3.8A) ATP A 801 (-4.1A) ATP A 801 (-4.7A)	1.01A	5aqfA-5e84A: 48.2	5aqfA-5e84A: 69.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5AQF_A_ADNA1382_1 (HEAT SHOCK COGNATE 71 KDA PROTEIN)	5e84	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	10 / 10	GLY A 227 GLY A 255 GLU A 293 LYS A 296 ARG A 297 SER A 300 GLY A 364 SER A 365 ARG A 367 ILE A 368	ATP A 801 (-3.8A) ATP A 801 (-3.5A) ATP A 801 (-2.5A) ATP A 801 (-2.7A) ATP A 801 (-3.8A) ATP A 801 (-2.6A) ATP A 801 (-3.1A) ATP A 801 (-3.8A) ATP A 801 (-4.1A) ATP A 801 (-4.7A)	0.54A	5aqfA-5e84A: 48.2	5aqfA-5e84A: 69.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5AQF_A_ADNA1382_1 (HEAT SHOCK COGNATE 71 KDA PROTEIN)	5e84	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	6 / 10	GLY A 254 GLY A 255 LYS A 296 SER A 300 SER A 365 ILE A 368	None ATP A 801 (-3.5A) ATP A 801 (-2.7A) ATP A 801 (-2.6A) ATP A 801 (-3.8A) ATP A 801 (-4.7A)	1.43A	5aqfA-5e84A: 48.2	5aqfA-5e84A: 69.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5AQF_C_ADNC1382_1 (HEAT SHOCK COGNATE 71 KDA PROTEIN)	5e84	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	6 / 10	GLY A 226 GLY A 254 GLU A 256 GLY A 364 SER A 365 ILE A 368	ATP A 801 (-3.3A) None None ATP A 801 (-3.1A) ATP A 801 (-3.8A) ATP A 801 (-4.7A)	1.49A	5aqfC-5e84A: 48.2	5aqfC-5e84A: 69.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5AQF_C_ADNC1382_1 (HEAT SHOCK COGNATE 71 KDA PROTEIN)	5e84	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	9 / 10	GLY A 226 GLY A 255 LYS A 296 ARG A 297 SER A 300 GLY A 364 SER A 365 ARG A 367 ILE A 368	ATP A 801 (-3.3A) ATP A 801 (-3.5A) ATP A 801 (-2.7A) ATP A 801 (-3.8A) ATP A 801 (-2.6A) ATP A 801 (-3.1A) ATP A 801 (-3.8A) ATP A 801 (-4.1A) ATP A 801 (-4.7A)	1.03A	5aqfC-5e84A: 48.2	5aqfC-5e84A: 69.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5AQF_C_ADNC1382_1 (HEAT SHOCK COGNATE 71 KDA PROTEIN)	5e84	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	10 / 10	GLY A 227 GLY A 255 GLU A 293 LYS A 296 ARG A 297 SER A 300 GLY A 364 SER A 365 ARG A 367 ILE A 368	ATP A 801 (-3.8A) ATP A 801 (-3.5A) ATP A 801 (-2.5A) ATP A 801 (-2.7A) ATP A 801 (-3.8A) ATP A 801 (-2.6A) ATP A 801 (-3.1A) ATP A 801 (-3.8A) ATP A 801 (-4.1A) ATP A 801 (-4.7A)	0.55A	5aqfC-5e84A: 48.2	5aqfC-5e84A: 69.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5AQF_C_ADNC1382_1 (HEAT SHOCK COGNATE 71 KDA PROTEIN)	5e84	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	5 / 10	GLY A 227 GLY A 255 GLY A 364 SER A 365 ILE A 371	ATP A 801 (-3.8A) ATP A 801 (-3.5A) ATP A 801 (-3.1A) ATP A 801 (-3.8A) None	1.04A	5aqfC-5e84A: 48.2	5aqfC-5e84A: 69.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5AQF_C_ADNC1382_1 (HEAT SHOCK COGNATE 71 KDA PROTEIN)	5e84	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	6 / 10	GLY A 254 GLY A 255 LYS A 296 SER A 300 SER A 365 ILE A 368	None ATP A 801 (-3.5A) ATP A 801 (-2.7A) ATP A 801 (-2.6A) ATP A 801 (-3.8A) ATP A 801 (-4.7A)	1.43A	5aqfC-5e84A: 48.2	5aqfC-5e84A: 69.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5AQY_A_ADNA1389_1 (HEAT SHOCK 70 KDA PROTEIN 1A)	5e84	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	6 / 10	GLY A 226 GLY A 254 GLU A 256 GLY A 364 SER A 365 ILE A 368	ATP A 801 (-3.3A) None None ATP A 801 (-3.1A) ATP A 801 (-3.8A) ATP A 801 (-4.7A)	1.43A	5aqyA-5e84A: 51.1	5aqyA-5e84A: 48.44
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5AQY_A_ADNA1389_1 (HEAT SHOCK 70 KDA PROTEIN 1A)	5e84	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	6 / 10	GLY A 226 GLY A 254 GLY A 364 SER A 365 ARG A 367 ILE A 368	ATP A 801 (-3.3A) None ATP A 801 (-3.1A) ATP A 801 (-3.8A) ATP A 801 (-4.1A) ATP A 801 (-4.7A)	1.22A	5aqyA-5e84A: 51.1	5aqyA-5e84A: 48.44
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5AQY_A_ADNA1389_1 (HEAT SHOCK 70 KDA PROTEIN 1A)	5e84	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	9 / 10	GLY A 226 GLY A 255 LYS A 296 ARG A 297 SER A 300 GLY A 364 SER A 365 ARG A 367 ILE A 368	ATP A 801 (-3.3A) ATP A 801 (-3.5A) ATP A 801 (-2.7A) ATP A 801 (-3.8A) ATP A 801 (-2.6A) ATP A 801 (-3.1A) ATP A 801 (-3.8A) ATP A 801 (-4.1A) ATP A 801 (-4.7A)	0.99A	5aqyA-5e84A: 51.1	5aqyA-5e84A: 48.44
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5AQY_A_ADNA1389_1 (HEAT SHOCK 70 KDA PROTEIN 1A)	5e84	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	6 / 10	GLY A 227 GLY A 254 GLY A 364 SER A 365 ARG A 367 ILE A 368	ATP A 801 (-3.8A) None ATP A 801 (-3.1A) ATP A 801 (-3.8A) ATP A 801 (-4.1A) ATP A 801 (-4.7A)	1.07A	5aqyA-5e84A: 51.1	5aqyA-5e84A: 48.44
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5AQY_A_ADNA1389_1 (HEAT SHOCK 70 KDA PROTEIN 1A)	5e84	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	10 / 10	GLY A 227 GLY A 255 GLU A 293 LYS A 296 ARG A 297 SER A 300 GLY A 364 SER A 365 ARG A 367 ILE A 368	ATP A 801 (-3.8A) ATP A 801 (-3.5A) ATP A 801 (-2.5A) ATP A 801 (-2.7A) ATP A 801 (-3.8A) ATP A 801 (-2.6A) ATP A 801 (-3.1A) ATP A 801 (-3.8A) ATP A 801 (-4.1A) ATP A 801 (-4.7A)	0.54A	5aqyA-5e84A: 51.1	5aqyA-5e84A: 48.44
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5AQY_A_ADNA1389_1 (HEAT SHOCK 70 KDA PROTEIN 1A)	5e84	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	6 / 10	GLY A 254 GLY A 255 LYS A 296 SER A 300 SER A 365 ILE A 368	None ATP A 801 (-3.5A) ATP A 801 (-2.7A) ATP A 801 (-2.6A) ATP A 801 (-3.8A) ATP A 801 (-4.7A)	1.45A	5aqyA-5e84A: 51.1	5aqyA-5e84A: 48.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5G5G_A_ACTA1231_0 (PUTATIVE XANTHINE DEHYDROGENASE YAGR MOLYBDENUM-BINDING SU SUBUNIT PUTATIVE XANTHINE DEHYDROGENASE YAGT IRON-SULFUR-BINDING SUBUNIT)	5e84	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	3 / 3	ARG A 289 THR A 38 ASP A 94	None ATP A 801 (-3.5A) None	0.91A	5g5gA-5e84A: undetectable 5g5gB-5e84A: undetectable	5g5gA-5e84A: 18.48 5g5gB-5e84A: 19.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ND4_B_TA1B601_1 (TUBULIN BETA-2B CHAIN)	5e84	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	5 / 12	VAL A 345 ASP A 348 SER A 233 PRO A 421 LEU A 422	None	1.25A	5nd4B-5e84A: undetectable	5nd4B-5e84A: 20.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5OGC_B_TA1B601_1 (TUBULIN BETA CHAIN)	5e84	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	5 / 12	VAL A 345 ASP A 348 SER A 233 PRO A 421 LEU A 422	None	1.22A	5ogcB-5e84A: undetectable	5ogcB-5e84A: 20.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5TIW_A_OAQA302_1 (SULFOTRANSFERASE)	5e84	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	4 / 4	TYR A 39 ASP A 391 ASP A 259 SER A 365	ATP A 801 (-4.8A) None ATP A 801 ( 4.9A) ATP A 801 (-3.8A)	1.40A	5tiwA-5e84A: 0.0	5tiwA-5e84A: 16.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5UTU_H_ADNH503_2 (ADENOSYLHOMOCYSTEINA SE)	5e84	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	4 / 5	THR A 508 GLU A 498 THR A 445 LEU A 424	None	1.35A	5utuH-5e84A: 2.0	5utuH-5e84A: 22.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6A7P_B_9SCB601_0 (SERUM ALBUMIN)	5e84	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	5 / 12	ILE A 199 VAL A 394 ALA A 204 PHE A 230 LEU A 253	None	1.37A	6a7pB-5e84A: undetectable	6a7pB-5e84A: 23.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6DIL_B_TPVB201_0 (HIV-1 PROTEASE)	5e84	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	5 / 12	LEU A 35 ASP A 391 VAL A 394 GLY A 226 PRO A 173	None None None ATP A 801 (-3.3A) ZN A 806 ( 4.6A)	0.86A	6dilA-5e84A: undetectable	6dilA-5e84A: 12.24

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1C8L_A_CFFA940_1","PROTEIN (GLYCOGEN PHOSPHORYLASE)","5e84","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",4,"ASN A 177;PHE A 176;ALA A 179;GLY A 100","None","1.08A","1c8lA-5e84A:undetectable","1c8lA-5e84A:21.19"],["1FBM_B_RTLB951_0","PROTEIN (CARTILAGE OLIGOMERIC MATRIX PROTEIN)","5e84","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",4,"THR A 557;LEU A 561;LEU A 568;GLN A 571","None","1.16A","1fbmA-5e84A:undetectable","1fbmA-5e84A:5.94"],["1GFZ_A_CFFA940_1","GLYCOGEN PHOSPHORYLASE","5e84","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",4,"ASN A 177;PHE A 176;ALA A 179;GLY A 100","None","1.06A","1gfzA-5e84A:undetectable","1gfzA-5e84A:21.19"],["1L5Q_A_CFFA863_1","GLYCOGEN PHOSPHORYLASE, LIVER FORM","5e84","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",4,"ASN A 177;PHE A 176;ALA A 179;GLY A 100","None","1.06A","1l5qA-5e84A:undetectable","1l5qA-5e84A:22.32"],["1L5Q_B_CFFB1863_1","GLYCOGEN PHOSPHORYLASE, LIVER FORM","5e84","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",4,"ASN A 177;PHE A 176;ALA A 179;GLY A 100","None","1.04A","1l5qB-5e84A:undetectable","1l5qB-5e84A:22.32"],["1L7X_A_CFFA863_1","GLYCOGEN PHOSPHORYLASE, LIVER FORM","5e84","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",4,"ASN A 177;PHE A 176;ALA A 179;GLY A 100","None","1.03A","1l7xA-5e84A:undetectable","1l7xA-5e84A:22.32"],["1L7X_B_CFFB1863_1","GLYCOGEN PHOSPHORYLASE, LIVER FORM","5e84","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",4,"ASN A 177;PHE A 176;ALA A 179;GLY A 100","None","1.05A","1l7xB-5e84A:undetectable","1l7xB-5e84A:22.32"],["1QHS_A_CLMA999_0","PROTEIN (CHLORAMPHENICOL PHOSPHOTRANSFERASE)","5e84","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",6,"VAL A 342;ILE A 359;ILE A 356;PHE A 379;VAL A 345;LEU A 234","None","1.38A","1qhsA-5e84A:undetectable","1qhsA-5e84A:16.45"],["1RJD_A_SAMA801_0","CARBOXY METHYL TRANSFERASE FOR PROTEIN PHOSPHATASE 2A CATALYTIC SUBUNIT","5e84","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",5,"ILE A 371;GLY A 254;GLY A 227;LEU A 334;LEU A 253","None;None;ATP A 801 (-3.8A);None;None","1.09A","1rjdA-5e84A:undetectable","1rjdA-5e84A:21.32"],["1RJD_B_SAMB802_0","CARBOXY METHYL TRANSFERASE FOR PROTEIN PHOSPHATASE 2A CATALYTIC SUBUNIT","5e84","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",5,"ILE A 371;GLY A 254;GLY A 227;LEU A 334;LEU A 253","None;None;ATP A 801 (-3.8A);None;None","1.07A","1rjdB-5e84A:undetectable","1rjdB-5e84A:21.32"],["1RJD_C_SAMC803_0","CARBOXY METHYL TRANSFERASE FOR PROTEIN PHOSPHATASE 2A CATALYTIC SUBUNIT","5e84","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",5,"ILE A 371;GLY A 254;GLY A 227;LEU A 334;LEU A 253","None;None;ATP A 801 (-3.8A);None;None","1.06A","1rjdC-5e84A:undetectable","1rjdC-5e84A:21.32"],["2B82_B_ADNB1002_1","CLASS B ACID PHOSPHATASE","5e84","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",5,"PHE A 612;LYS A 616;LEU A 601;TRP A 600;THR A 557","None","1.35A","2b82B-5e84A:undetectable","2b82B-5e84A:16.31"],["2BM9_C_SAMC301_1","CEPHALOSPORIN HYDROXYLASE CMCI","5e84","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",4,"SER A 146;ASP A  94;ARG A 289;ASP A 259","None;None;None;ATP A 801 ( 4.9A)","1.48A","2bm9C-5e84A:undetectable","2bm9C-5e84A:15.17"],["2IEO_A_017A402_1","PROTEASE","5e84","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",5,"LEU A  35;ASP A 391;VAL A 394;GLY A 226;PRO A 173","None;None;None;ATP A 801 (-3.3A); ZN A 806 ( 4.6A)","0.95A","2ieoA-5e84A:undetectable","2ieoA-5e84A:11.38"],["2IEO_A_017A402_2","PROTEASE;PROTEASE","5e84","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",5,"LEU A  35;ASP A 391;VAL A 394;GLY A 226;PRO A 173","None;None;None;ATP A 801 (-3.3A); ZN A 806 ( 4.6A)","0.89A","2ieoB-5e84A:undetectable","2ieoB-5e84A:11.38"],["2Q6O_B_SAMB500_0","HYPOTHETICAL PROTEIN","5e84","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",4,"ASP A 224;VAL A 362;PRO A 173;THR A 171"," ZN A 806 (-2.7A);None; ZN A 806 ( 4.6A);None","1.43A","2q6oB-5e84A:undetectable","2q6oB-5e84A:18.74"],["2YA7_C_ZMRC1776_2","NEURAMINIDASE A","5e84","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",4,"ASP A 186;ILE A 190;GLU A 533;TYR A 127","None","1.34A","2ya7C-5e84A:undetectable","2ya7C-5e84A:22.93"],["3AOB_C_RFPC2002_1","ACRIFLAVINE RESISTANCE PROTEIN B","5e84","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",5,"ALA A 179;THR A 102;GLY A 476;ARG A 528;LEU A 424","None","1.43A","3aobC-5e84A:2.9","3aobC-5e84A:19.70"],["3ARR_A_PNXA606_1","CHITINASE A","5e84","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",4,"GLY A 210;LYS A 213;ASP A 357;TYR A 209","None","1.34A","3arrA-5e84A:undetectable","3arrA-5e84A:23.08"],["3BCR_A_AZZA940_1","GLYCOGEN PHOSPHORYLASE, MUSCLE FORM","5e84","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",4,"ASN A 177;PHE A 176;ALA A 179;GLY A 100","None","1.11A","3bcrA-5e84A:undetectable","3bcrA-5e84A:21.19"],["3CYW_A_017A201_1","HIV-1 PROTEASE","5e84","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",5,"LEU A  35;ASP A 391;VAL A 394;GLY A 226;PRO A 173","None;None;None;ATP A 801 (-3.3A); ZN A 806 ( 4.6A)","0.86A","3cywA-5e84A:undetectable","3cywA-5e84A:11.38"],["3D20_A_017A201_2","HIV-1 PROTEASE;HIV-1 PROTEASE","5e84","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",5,"LEU A  35;ASP A 391;VAL A 394;GLY A 226;PRO A 173","None;None;None;ATP A 801 (-3.3A); ZN A 806 ( 4.6A)","0.90A","3d20B-5e84A:undetectable","3d20B-5e84A:11.21"],["3DD1_A_CFFA903_1","GLYCOGEN PHOSPHORYLASE, LIVER FORM","5e84","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",4,"ASN A 177;PHE A 176;ALA A 179;GLY A 100","None","1.07A","3dd1A-5e84A:undetectable","3dd1A-5e84A:22.21"],["3DD1_B_CFFB903_1","GLYCOGEN PHOSPHORYLASE, LIVER FORM","5e84","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",4,"ASN A 177;PHE A 176;ALA A 179;GLY A 100","None","1.06A","3dd1B-5e84A:undetectable","3dd1B-5e84A:22.21"],["3DDS_A_CFFA904_1","GLYCOGEN PHOSPHORYLASE, LIVER FORM","5e84","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",4,"ASN A 177;PHE A 176;ALA A 179;GLY A 100","None","1.06A","3ddsA-5e84A:undetectable","3ddsA-5e84A:22.21"],["3DDS_B_CFFB903_1","GLYCOGEN PHOSPHORYLASE, LIVER FORM","5e84","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",4,"ASN A 177;PHE A 176;ALA A 179;GLY A 100","None","1.04A","3ddsB-5e84A:undetectable","3ddsB-5e84A:22.21"],["3DDW_A_CFFA903_1","GLYCOGEN PHOSPHORYLASE, LIVER FORM","5e84","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",4,"ASN A 177;PHE A 176;ALA A 179;GLY A 100","None","1.08A","3ddwA-5e84A:undetectable","3ddwA-5e84A:22.21"],["3DDW_B_CFFB903_1","GLYCOGEN PHOSPHORYLASE, LIVER FORM","5e84","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",4,"ASN A 177;PHE A 176;ALA A 179;GLY A 100","None","1.06A","3ddwB-5e84A:undetectable","3ddwB-5e84A:22.21"],["3EKT_D_017D200_2","PROTEASE","5e84","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",5,"LEU A  35;ASP A 391;VAL A 394;GLY A 226;PRO A 173","None;None;None;ATP A 801 (-3.3A); ZN A 806 ( 4.6A)","0.89A","3ektD-5e84A:undetectable","3ektD-5e84A:10.70"],["3HLW_B_CE3B302_2","CTX-M-9 EXTENDED-SPECTRUM BETA-LACTAMASE","5e84","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",3,"CYH A  41;PRO A  63;ASP A 391","None","0.94A","3hlwB-5e84A:undetectable","3hlwB-5e84A:19.03"],["3J6P_B_TA1B502_1","TUBULIN BETA CHAIN","5e84","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",5,"VAL A 345;ASP A 348;SER A 233;PRO A 421;LEU A 422","None","1.31A","3j6pB-5e84A:undetectable","3j6pB-5e84A:20.92"],["3LZU_A_017A200_1","HIV-1 PROTEASE","5e84","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",5,"LEU A  35;ASP A 391;VAL A 394;GLY A 226;PRO A 173","None;None;None;ATP A 801 (-3.3A); ZN A 806 ( 4.6A)","0.90A","3lzuA-5e84A:undetectable","3lzuA-5e84A:11.54"],["3MBG_A_ACTA207_0","FAD-LINKED SULFHYDRYL OXIDASE ALR","5e84","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",4,"GLU A 201;LYS A  96;ASP A 231;ALA A 229"," ZN A 806 ( 2.6A);ATP A 801 (-2.3A); ZN A 806 (-2.8A);ATP A 801 (-4.1A)","1.17A","3mbgA-5e84A:undetectable;3mbgB-5e84A:undetectable","3mbgA-5e84A:11.55;3mbgB-5e84A:11.55"],["3OXX_A_DR7A100_1","HIV-1 PROTEASE","5e84","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",5,"LEU A  35;ASP A 391;VAL A 394;GLY A 226;PRO A 173","None;None;None;ATP A 801 (-3.3A); ZN A 806 ( 4.6A)","0.88A","3oxxA-5e84A:undetectable","3oxxA-5e84A:11.71"],["3S3M_A_DLUA398_1","PFV INTEGRASE","5e84","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",4,"ASP A 224;GLY A 364;TYR A  39;GLU A 201"," ZN A 806 (-2.7A);ATP A 801 (-3.1A);ATP A 801 (-4.8A); ZN A 806 ( 2.6A)","0.88A","3s3mA-5e84A:3.7","3s3mA-5e84A:22.71"],["3S3N_A_DLUA398_1","PFV INTEGRASE","5e84","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",4,"ASP A 224;GLY A 364;TYR A  39;GLU A 201"," ZN A 806 (-2.7A);ATP A 801 (-3.1A);ATP A 801 (-4.8A); ZN A 806 ( 2.6A)","0.90A","3s3nA-5e84A:3.5","3s3nA-5e84A:22.71"],["3SPK_B_TPVB100_2","HIV-1 PROTEASE","5e84","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",5,"LEU A  35;ASP A 391;VAL A 394;GLY A 226;PRO A 173","None;None;None;ATP A 801 (-3.3A); ZN A 806 ( 4.6A)","0.98A","3spkB-5e84A:undetectable","3spkB-5e84A:10.87"],["4A97_B_ZPCB1318_1","CYS-LOOP LIGAND-GATED ION CHANNEL;CYS-LOOP LIGAND-GATED ION CHANNEL","5e84","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",5,"PHE A 544;ILE A 145;GLU A 547;GLU A 155;VAL A  92","None","1.41A","4a97A-5e84A:2.7;4a97B-5e84A:4.0","4a97A-5e84A:19.60;4a97B-5e84A:19.60"],["4K50_I_ACTI504_0","RNA POLYMERASE 3D-POL","5e84","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",3,"VAL A  66;GLY A  77;LYS A  81","None","0.52A","4k50I-5e84A:undetectable","4k50I-5e84A:23.64"],["4MM4_A_8PRA603_1","TRANSPORTER","5e84","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",5,"ALA A 398;TYR A 396;PHE A  45;GLY A  43;THR A 411","None","1.36A","4mm4A-5e84A:undetectable","4mm4A-5e84A:22.76"],["4NJU_A_TPVA500_1","PROTEASE","5e84","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",5,"LEU A  35;ASP A 391;VAL A 394;GLY A 226;PRO A 173","None;None;None;ATP A 801 (-3.3A); ZN A 806 ( 4.6A)","0.87A","4njuA-5e84A:undetectable","4njuA-5e84A:10.62"],["4NJU_C_TPVC500_1","PROTEASE","5e84","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",5,"LEU A  35;ASP A 391;VAL A 394;GLY A 226;PRO A 173","None;None;None;ATP A 801 (-3.3A); ZN A 806 ( 4.6A)","0.87A","4njuC-5e84A:undetectable","4njuC-5e84A:10.62"],["4O1E_A_C2FA3000_0","DIHYDROPTEROATE SYNTHASE DHPS","5e84","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",5,"GLU A 143;ILE A 534;GLY A 100;LYS A 123;ILE A  99","None","1.07A","4o1eA-5e84A:undetectable","4o1eA-5e84A:18.87"],["4OBW_A_SAMA602_0","2-METHOXY-6-POLYPRENYL-1,4-BENZOQUINOL METHYLASE, MITOCHONDRIAL","5e84","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",5,"GLY A 216;ILE A 220;ASN A 219;GLY A 210;PHE A 242","None","1.24A","4obwA-5e84A:undetectable","4obwA-5e84A:18.36"],["4OBW_B_SAMB601_0","2-METHOXY-6-POLYPRENYL-1,4-BENZOQUINOL METHYLASE, MITOCHONDRIAL","5e84","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",5,"ALA A 229;GLY A 228;GLY A 227;ASP A  94;GLY A 249","ATP A 801 (-4.1A);ATP A 801 (-4.1A);ATP A 801 (-3.8A);None;None","1.00A","4obwB-5e84A:undetectable","4obwB-5e84A:18.36"],["4OBW_C_SAMC601_0","2-METHOXY-6-POLYPRENYL-1,4-BENZOQUINOL METHYLASE, MITOCHONDRIAL","5e84","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",5,"GLY A 216;ILE A 220;ASN A 219;GLY A 210;PHE A 242","None","1.22A","4obwC-5e84A:undetectable","4obwC-5e84A:18.36"],["4OBW_D_SAMD601_0","2-METHOXY-6-POLYPRENYL-1,4-BENZOQUINOL METHYLASE, MITOCHONDRIAL","5e84","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",5,"GLY A 216;ILE A 220;ASN A 219;GLY A 210;PHE A 242","None","1.24A","4obwD-5e84A:undetectable","4obwD-5e84A:18.36"],["4PM5_A_CE3A301_2","BETA-LACTAMASE CTX-M-14","5e84","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",3,"CYH A  41;PRO A  63;ASP A 391","None","0.93A","4pm5A-5e84A:undetectable","4pm5A-5e84A:18.86"],["4QWP_B_GCSB307_1","CHITOSANASE","5e84","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",4,"GLU A 201;THR A  37;GLY A  36;THR A  38"," ZN A 806 ( 2.6A);ATP A 801 (-4.0A);ATP A 801 (-3.2A);ATP A 801 (-3.5A)","0.90A","4qwpB-5e84A:2.2","4qwpB-5e84A:18.60"],["4ZGF_A_BEZA210_0","UNCHARACTERIZED PROTEIN","5e84","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",4,"VAL A  66;ALA A  67;ASN A  90;GLN A  83","None","1.42A","4zgfA-5e84A:undetectable","4zgfA-5e84A:12.87"],["5AQF_A_ADNA1382_1","HEAT SHOCK COGNATE 71 KDA PROTEIN","5e84","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",6,"GLY A 226;GLY A 254;GLU A 256;GLY A 364;SER A 365;ILE A 368","ATP A 801 (-3.3A);None;None;ATP A 801 (-3.1A);ATP A 801 (-3.8A);ATP A 801 (-4.7A)","1.47A","5aqfA-5e84A:48.2","5aqfA-5e84A:69.53"],["5AQF_A_ADNA1382_1","HEAT SHOCK COGNATE 71 KDA PROTEIN","5e84","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",9,"GLY A 226;GLY A 255;LYS A 296;ARG A 297;SER A 300;GLY A 364;SER A 365;ARG A 367;ILE A 368","ATP A 801 (-3.3A);ATP A 801 (-3.5A);ATP A 801 (-2.7A);ATP A 801 (-3.8A);ATP A 801 (-2.6A);ATP A 801 (-3.1A);ATP A 801 (-3.8A);ATP A 801 (-4.1A);ATP A 801 (-4.7A)","1.01A","5aqfA-5e84A:48.2","5aqfA-5e84A:69.53"],["5AQF_A_ADNA1382_1","HEAT SHOCK COGNATE 71 KDA PROTEIN","5e84","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",10,"GLY A 227;GLY A 255;GLU A 293;LYS A 296;ARG A 297;SER A 300;GLY A 364;SER A 365;ARG A 367;ILE A 368","ATP A 801 (-3.8A);ATP A 801 (-3.5A);ATP A 801 (-2.5A);ATP A 801 (-2.7A);ATP A 801 (-3.8A);ATP A 801 (-2.6A);ATP A 801 (-3.1A);ATP A 801 (-3.8A);ATP A 801 (-4.1A);ATP A 801 (-4.7A)","0.54A","5aqfA-5e84A:48.2","5aqfA-5e84A:69.53"],["5AQF_A_ADNA1382_1","HEAT SHOCK COGNATE 71 KDA PROTEIN","5e84","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",6,"GLY A 254;GLY A 255;LYS A 296;SER A 300;SER A 365;ILE A 368","None;ATP A 801 (-3.5A);ATP A 801 (-2.7A);ATP A 801 (-2.6A);ATP A 801 (-3.8A);ATP A 801 (-4.7A)","1.43A","5aqfA-5e84A:48.2","5aqfA-5e84A:69.53"],["5AQF_C_ADNC1382_1","HEAT SHOCK COGNATE 71 KDA PROTEIN","5e84","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",6,"GLY A 226;GLY A 254;GLU A 256;GLY A 364;SER A 365;ILE A 368","ATP A 801 (-3.3A);None;None;ATP A 801 (-3.1A);ATP A 801 (-3.8A);ATP A 801 (-4.7A)","1.49A","5aqfC-5e84A:48.2","5aqfC-5e84A:69.53"],["5AQF_C_ADNC1382_1","HEAT SHOCK COGNATE 71 KDA PROTEIN","5e84","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",9,"GLY A 226;GLY A 255;LYS A 296;ARG A 297;SER A 300;GLY A 364;SER A 365;ARG A 367;ILE A 368","ATP A 801 (-3.3A);ATP A 801 (-3.5A);ATP A 801 (-2.7A);ATP A 801 (-3.8A);ATP A 801 (-2.6A);ATP A 801 (-3.1A);ATP A 801 (-3.8A);ATP A 801 (-4.1A);ATP A 801 (-4.7A)","1.03A","5aqfC-5e84A:48.2","5aqfC-5e84A:69.53"],["5AQF_C_ADNC1382_1","HEAT SHOCK COGNATE 71 KDA PROTEIN","5e84","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",10,"GLY A 227;GLY A 255;GLU A 293;LYS A 296;ARG A 297;SER A 300;GLY A 364;SER A 365;ARG A 367;ILE A 368","ATP A 801 (-3.8A);ATP A 801 (-3.5A);ATP A 801 (-2.5A);ATP A 801 (-2.7A);ATP A 801 (-3.8A);ATP A 801 (-2.6A);ATP A 801 (-3.1A);ATP A 801 (-3.8A);ATP A 801 (-4.1A);ATP A 801 (-4.7A)","0.55A","5aqfC-5e84A:48.2","5aqfC-5e84A:69.53"],["5AQF_C_ADNC1382_1","HEAT SHOCK COGNATE 71 KDA PROTEIN","5e84","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",5,"GLY A 227;GLY A 255;GLY A 364;SER A 365;ILE A 371","ATP A 801 (-3.8A);ATP A 801 (-3.5A);ATP A 801 (-3.1A);ATP A 801 (-3.8A);None","1.04A","5aqfC-5e84A:48.2","5aqfC-5e84A:69.53"],["5AQF_C_ADNC1382_1","HEAT SHOCK COGNATE 71 KDA PROTEIN","5e84","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",6,"GLY A 254;GLY A 255;LYS A 296;SER A 300;SER A 365;ILE A 368","None;ATP A 801 (-3.5A);ATP A 801 (-2.7A);ATP A 801 (-2.6A);ATP A 801 (-3.8A);ATP A 801 (-4.7A)","1.43A","5aqfC-5e84A:48.2","5aqfC-5e84A:69.53"],["5AQY_A_ADNA1389_1","HEAT SHOCK 70 KDA PROTEIN 1A","5e84","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",6,"GLY A 226;GLY A 254;GLU A 256;GLY A 364;SER A 365;ILE A 368","ATP A 801 (-3.3A);None;None;ATP A 801 (-3.1A);ATP A 801 (-3.8A);ATP A 801 (-4.7A)","1.43A","5aqyA-5e84A:51.1","5aqyA-5e84A:48.44"],["5AQY_A_ADNA1389_1","HEAT SHOCK 70 KDA PROTEIN 1A","5e84","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",6,"GLY A 226;GLY A 254;GLY A 364;SER A 365;ARG A 367;ILE A 368","ATP A 801 (-3.3A);None;ATP A 801 (-3.1A);ATP A 801 (-3.8A);ATP A 801 (-4.1A);ATP A 801 (-4.7A)","1.22A","5aqyA-5e84A:51.1","5aqyA-5e84A:48.44"],["5AQY_A_ADNA1389_1","HEAT SHOCK 70 KDA PROTEIN 1A","5e84","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",9,"GLY A 226;GLY A 255;LYS A 296;ARG A 297;SER A 300;GLY A 364;SER A 365;ARG A 367;ILE A 368","ATP A 801 (-3.3A);ATP A 801 (-3.5A);ATP A 801 (-2.7A);ATP A 801 (-3.8A);ATP A 801 (-2.6A);ATP A 801 (-3.1A);ATP A 801 (-3.8A);ATP A 801 (-4.1A);ATP A 801 (-4.7A)","0.99A","5aqyA-5e84A:51.1","5aqyA-5e84A:48.44"],["5AQY_A_ADNA1389_1","HEAT SHOCK 70 KDA PROTEIN 1A","5e84","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",6,"GLY A 227;GLY A 254;GLY A 364;SER A 365;ARG A 367;ILE A 368","ATP A 801 (-3.8A);None;ATP A 801 (-3.1A);ATP A 801 (-3.8A);ATP A 801 (-4.1A);ATP A 801 (-4.7A)","1.07A","5aqyA-5e84A:51.1","5aqyA-5e84A:48.44"],["5AQY_A_ADNA1389_1","HEAT SHOCK 70 KDA PROTEIN 1A","5e84","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",10,"GLY A 227;GLY A 255;GLU A 293;LYS A 296;ARG A 297;SER A 300;GLY A 364;SER A 365;ARG A 367;ILE A 368","ATP A 801 (-3.8A);ATP A 801 (-3.5A);ATP A 801 (-2.5A);ATP A 801 (-2.7A);ATP A 801 (-3.8A);ATP A 801 (-2.6A);ATP A 801 (-3.1A);ATP A 801 (-3.8A);ATP A 801 (-4.1A);ATP A 801 (-4.7A)","0.54A","5aqyA-5e84A:51.1","5aqyA-5e84A:48.44"],["5AQY_A_ADNA1389_1","HEAT SHOCK 70 KDA PROTEIN 1A","5e84","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",6,"GLY A 254;GLY A 255;LYS A 296;SER A 300;SER A 365;ILE A 368","None;ATP A 801 (-3.5A);ATP A 801 (-2.7A);ATP A 801 (-2.6A);ATP A 801 (-3.8A);ATP A 801 (-4.7A)","1.45A","5aqyA-5e84A:51.1","5aqyA-5e84A:48.44"],["5G5G_A_ACTA1231_0","PUTATIVE XANTHINE DEHYDROGENASE YAGR MOLYBDENUM-BINDING SU SUBUNIT;PUTATIVE XANTHINE DEHYDROGENASE YAGT IRON-SULFUR-BINDING SUBUNIT","5e84","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",3,"ARG A 289;THR A  38;ASP A  94","None;ATP A 801 (-3.5A);None","0.91A","5g5gA-5e84A:undetectable;5g5gB-5e84A:undetectable","5g5gA-5e84A:18.48;5g5gB-5e84A:19.84"],["5ND4_B_TA1B601_1","TUBULIN BETA-2B CHAIN","5e84","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",5,"VAL A 345;ASP A 348;SER A 233;PRO A 421;LEU A 422","None","1.25A","5nd4B-5e84A:undetectable","5nd4B-5e84A:20.91"],["5OGC_B_TA1B601_1","TUBULIN BETA CHAIN","5e84","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",5,"VAL A 345;ASP A 348;SER A 233;PRO A 421;LEU A 422","None","1.22A","5ogcB-5e84A:undetectable","5ogcB-5e84A:20.92"],["5TIW_A_OAQA302_1","SULFOTRANSFERASE","5e84","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",4,"TYR A  39;ASP A 391;ASP A 259;SER A 365","ATP A 801 (-4.8A);None;ATP A 801 ( 4.9A);ATP A 801 (-3.8A)","1.40A","5tiwA-5e84A:0.0","5tiwA-5e84A:16.94"],["5UTU_H_ADNH503_2","ADENOSYLHOMOCYSTEINASE","5e84","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",4,"THR A 508;GLU A 498;THR A 445;LEU A 424","None","1.35A","5utuH-5e84A:2.0","5utuH-5e84A:22.52"],["6A7P_B_9SCB601_0","SERUM ALBUMIN","5e84","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",5,"ILE A 199;VAL A 394;ALA A 204;PHE A 230;LEU A 253","None","1.37A","6a7pB-5e84A:undetectable","6a7pB-5e84A:23.50"],["6DIL_B_TPVB201_0","HIV-1 PROTEASE","5e84","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",5,"LEU A  35;ASP A 391;VAL A 394;GLY A 226;PRO A 173","None;None;None;ATP A 801 (-3.3A); ZN A 806 ( 4.6A)","0.86A","6dilA-5e84A:undetectable","6dilA-5e84A:12.24"]]